objective evaluate effect combined chemoradiotherapy followed surgery patients esophageal carcinoma methods patients stage ii iii esophageal carcinoma contraindication operation chemoradiotherapy randomly divided groups combined group group NUMBER control group group b NUMBER patients group given neoadjuvant treatment consisted chemotherapy cisplatin NUMBER cycles radiotherapy dt36 f17 d weeks later operation performed patients group b given operation survival rate calculated method chi test used assess difference groups results radical resectability group group b NUMBER NUMBER p NUMBER NUMBER lymph node metastasis rate groups NUMBER NUMBER p NUMBER NUMBER t stage group significantly lowered p NUMBER NUMBER local regional recurrence rate groups NUMBER NUMBER p NUMBER NUMBER significant difference operative complications groups significant improvement survival rate observed group especially patients achieved partial complete response high survival rate NUMBER conclusion preoperative neoadjuvant chemoradiotherapy able reduce tumor tumor stage lower lymph node metastasis rate local regional recurrence rate improve radical resectability survival increasing operative complications ninety seven NUMBER fluorouracil kaplan meier log rank long term NUMBER year long term gy NUMBER